Department of Medicine (M.D.M., L.H., A.S., A.M., S.P., M.Z., I.B.d.S., M.G.B., J.R., D.D.), Rush University Medical Center.
Jesse Brown VA Medical Center (M.D.M., D.D.), Rush University Medical Center.
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008296. doi: 10.1161/CIRCEP.120.008296. Epub 2020 Jul 12.
Epidemiological studies have established obesity as an independent risk factor for atrial fibrillation (AF), but the underlying pathophysiological mechanisms remain unclear. Reduced cardiac sodium channel expression is a known causal mechanism in AF. We hypothesized that obesity decreases Nav1.5 expression via enhanced oxidative stress, thus reducing , and enhancing susceptibility to AF.
To elucidate the underlying electrophysiological mechanisms a diet-induced obese mouse model was used. Weight, blood pressure, glucose, F-isoprostanes, NOX2 (NADPH oxidase 2), and PKC (protein kinase C) were measured in obese mice and compared with lean controls. Invasive electrophysiological, immunohistochemistry, Western blotting, and patch clamping of membrane potentials was performed to evaluate the molecular and electrophysiological phenotype of atrial myocytes.
Pacing-induced AF in 100% of diet-induced obese mice versus 25% in controls (<0.01) with increased AF burden. Cardiac sodium channel expression, and atrial action potential duration were reduced and potassium channel expression (Kv1.5) and current () and F-isoprostanes, NOX2, and PKC-α/δ expression and atrial fibrosis were significantly increased in diet-induced obese mice as compared with controls. A mitochondrial antioxidant reduced AF burden, restored , , , action potential duration, and reversed atrial fibrosis in diet-induced obese mice as compared with controls.
Inducible AF in obese mice is mediated, in part, by a combined effect of sodium, potassium, and calcium channel remodeling and atrial fibrosis. Mitochondrial antioxidant therapy abrogated the ion channel and structural remodeling and reversed the obesity-induced AF burden. Our findings have important implications for the management of obesity-mediated AF in patients. Graphic Abstract: A graphic abstract is available for this article.
流行病学研究已经确定肥胖是心房颤动(AF)的独立危险因素,但潜在的病理生理机制仍不清楚。心脏钠通道表达减少是 AF 的已知因果机制。我们假设肥胖通过增强氧化应激降低 Nav1.5 表达,从而降低 ,并增强对 AF 的易感性。
为了阐明潜在的电生理机制,使用了一种饮食诱导肥胖的小鼠模型。测量肥胖小鼠和瘦对照的体重、血压、血糖、F-异前列烷、NOX2(NADPH 氧化酶 2)和 PKC(蛋白激酶 C)。进行侵入性电生理、免疫组织化学、Western 印迹和膜电位贴片钳以评估心房肌细胞的分子和电生理表型。
起搏诱导的 AF 在 100%的饮食诱导肥胖小鼠中发生,而在对照组中为 25%(<0.01),AF 负荷增加。与对照组相比,心脏钠通道表达、 以及心房动作电位时程降低,钾通道表达(Kv1.5)和电流( )和 F-异前列烷、NOX2 和 PKC-α/δ 表达以及心房纤维化显著增加在饮食诱导肥胖的小鼠中与对照组相比。与对照组相比,线粒体抗氧化剂减少了 AF 负荷,恢复了 、 、 、动作电位时程,并逆转了饮食诱导肥胖的小鼠的心房纤维化。
肥胖小鼠的可诱导 AF 部分是由钠、钾和钙通道重塑以及心房纤维化的综合作用介导的。线粒体抗氧化剂治疗消除了离子通道和结构重塑,并逆转了肥胖引起的 AF 负荷。我们的发现对肥胖介导的 AF 患者的管理具有重要意义。